E. Kevin Hrusovsky
Net Worth
Last updated:
What is E. Kevin Hrusovsky net worth?
The estimated net worth of Mr. E. Kevin Hrusovsky is at least $21,794,540 as of 5 Jul 2022. He owns shares worth $4,551,336 as insider, has earned $6,603,204 from insider trading and has received compensation worth at least $10,640,000 in Quanterix Corporation.
What is the salary of E. Kevin Hrusovsky?
Mr. E. Kevin Hrusovsky salary is $1,330,000 per year as Chairman & Chief Executive Officer in Quanterix Corporation.
How old is E. Kevin Hrusovsky?
Mr. E. Kevin Hrusovsky is 63 years old, born in 1962.
What stocks does E. Kevin Hrusovsky currently own?
As insider, Mr. E. Kevin Hrusovsky owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Quanterix Corporation (QTRX) | Chairman & Chief Executive Officer | 910,249 | $5 | $4,551,336 |
What does Quanterix Corporation do?
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
E. Kevin Hrusovsky insider trading
Quanterix Corporation
Mr. E. Kevin Hrusovsky has made 122 insider trades between 2017-2022, according to the Form 4 filled with the SEC. Most recently he sold 960 units of QTRX stock worth $15,906 on 5 Jul 2022.
The largest trade he's ever made was exercising 34,000 units of QTRX stock on 11 Dec 2017. As of 5 Jul 2022 he still owns at least 910,249 units of QTRX stock.
Quanterix key executives
Quanterix Corporation executives and other stock owners filed with the SEC:
- Dr. David R. Walt Ph.D. (72) Co-Founder, Chairman of Scientific Advisory Board & Independent Director
- Mr. E. Kevin Hrusovsky (63) Chairman & Chief Executive Officer